Prescription pill bottles displayed in a pharmacy, representing changes in U.S. drug pricing policy under the Inflation Reduction Act and its potential impact on innovation and patient access.

How the Inflation Reduction Act Could Affect Drug Innovation, Biosimilars, and Patient Access

BIPOC News, Health Policy, Top Stories /

WASHINGTON — The Inflation Reduction Act (IRA), passed in 2022, changed the way the federal government handles prescription drug prices. The law allows Medicare to negotiate the price of certain […]

How the Inflation Reduction Act Could Affect Drug Innovation, Biosimilars, and Patient Access Read More »